Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports

Joost J. Enzing*, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer, Werner B.F. Brouwer

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)
20 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports'. Together they form a unique fingerprint.

Social Sciences

Economics, Econometrics and Finance